Grin.Cd

GRIN.CD's capital structure is characterized by a debt-to-equity ratio of 0.61, indicating a moderate reliance on debt financing. The company holds $11,371,830 in cash and equivalents, but this is offset by $12,816,010 in long-term debt, resulting in a net cash position that is negative. Free cash flow is negative at -$726,790, suggesting that capital expenditures are outpacing operating cash flow. The current ratio of 3.87 indicates strong short-term liquidity, with current assets significantly exceeding current liabilities.

Profitability metrics show mixed results. Return on equity (ROE) is 8.28%, which is relatively strong, but return on assets (ROA) is only 2.76%, indicating that the company is not efficiently utilizing its assets to generate returns. Operating income is negative at -$593,480, which contrasts with a net income of $1,729,810, suggesting that non-operating income or gains are contributing to profitability. Gross profit of $14,146,690 represents 43.6% of revenue, which is a healthy margin for a pharmaceutical company.

Segment and geographic exposure data are not available in the provided input, so it is not possible to assess revenue concentration or geographic diversification. However, the absence of detailed segment reporting may indicate a lack of diversification or a focus on a single product line or therapeutic area.

Growth trajectory is difficult to assess due to the lack of historical revenue data, but the current FY outlook is not provided in the input. The company's operating cash flow of $3,569,800 and capital expenditures of -$4,659,010 suggest that it is investing in long-term growth, albeit at the expense of free cash flow. The negative operating income indicates that the company is not yet profitable from its core operations.

Risk factors include a medium liquidity risk, as the company's net cash position is negative after accounting for long-term debt. Dilution risk is assessed as low, with no significant dilution potential reported in the input data. The risk assessment does not provide a detailed breakdown of other risk factors, but the negative operating income and negative free cash flow suggest operational and financial risks that could impact future performance.

Recent events and filings are not detailed in the input data, so it is not possible to assess the impact of recent developments on the company's financial position or strategic direction. The absence of recent transcript data or filings may indicate a lack of public disclosure or a smaller market presence.